city New Delhi India covid-19 recommendations patient city New Delhi India

WHO panel gives go-ahead for monoclonal antibody therapy on two covid categories

Reading now: 377
www.livemint.com

NEW DELHI : A World Health Organization (WHO) panel on Friday gave its green signal to monoclonal antibodies therapy for management of two categories of covid-19 patients.

A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a WHO Guideline Development Group (GDG) panel of international experts.

Casirivimab and imdevimab are monoclonal antibodies that when used together bind to the SARS-CoV-2 spike protein, neutralizing the virus’s ability to infect cells.

The panel recommended it for patients with non-severe covid-19, who are at highest risk of hospitalization and those with severe or critical covid-19 who are seronegative, meaning they have not mounted their

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA